Agenda Announced for the 2019 Biopharmaceutical Formulation Group Meeting
Posted on 14/06/2019
KTN is hosting this year’s Biopharmaceutical Formulation Group Meeting, titled ‘Formulation solutions for diversifying biopharmaceutical portfolios’. It will be held at Manchester’s Centre of Excellence in Biopharmaceuticals (COEBP) in the Manchester Institute of Biotechnology (MIB) on 11th July 2019.
The Biopharmaceutical Formulation Group (BFG) brings together professionals and practitioners from industry and academia to disseminate and share best practice and highlight areas of need for this sector. This BFG meeting will address the diversification of the products within the biopharmaceutical portfolio, and how fundamental science and understanding developed by the UK formulation community is directing towards effective and predictive solutions for formulation of new biologics and therapeutic formats. This meeting will present on the fundamentals and application of formulation development for existing and emerging biomedicines.
09:30 – 10:00: Registration, coffee, networking, poster viewing and 1-2-1 Partnering.
10:00 – 10:05: Welcome. Alan Dickson, University of Manchester
Morning session. Chair: Richard Zajicek, GlaxoSmithKline.
10:05 – 10:20: KTN update. Marcel Kuiper, Knowledge Transfer Network.
10:20 – 10:40: Coformulated therapies. Formulation and analytical challenges. Paul Dalby, University College London.
10:40 – 11:50: Interactive session facilitated by Marcel Kuiper, Knowledge Transfer Network.
11:50 – 12:10: Formulation of soluble, bi-specific TCRs: from discovery to development. Priscilla Ranglani, Immunocore.
12:10 – 12:30: Relevance of protein adsorption to biopharmaceutical formulation. Jian Lu, University of Manchester.
12:30 – 13:00: Poster Flashes. Brief introduction to posters selected by the Biopharmaceutical Formulation Group.
13:00 – 14:00: Lunch, networking, poster viewing and 1-2-1 Partnering.
Afternoon session. Chair: Shahid Uddin, Immunocore.
14:00 – 14:20: Breadth of exosome therapeutics – breadth of formulation challenges. Bo Kara, Evox Therapeutics.
14:20 – 14:40: Harnessing the body to make therapeutic proteins. Chris van der Walle, AstraZeneca.
14:40 – 15:00: Formulation considerations for antibody drug conjugates Allan Davidson, Piramal Healthcare.
15:00 – 14:30: Coffee, networking, poster viewing and 1-2-1 Partnering.
15:30 – 15:50: Title TBC. Jennifer McManus, Maynooth University, Republic of Ireland.
15:50 – 16:25: Panel Session: BFG Advisory Panel. Summary, discussion and feedback on the event, as well as discussion about the status of the BFG community and its challenges.
15:50 – 16:25: Close. Alan Dickson, University of Manchester.
There will be an opportunity to organise 1-2-1 partnering meetings, to maximise opportunities for interaction and future collaborations. In addition to oral presentations there will be the chance to present posters. Selected poster presenters will be invited to present a poster flash and there will be prizes for the best posters. The deadline for expressions of interest to for poster presentations is 26th June 2019.
To support attendance of early careers scientists (PhD or first three years of post-doc or industry), we are offering a number of bursaries to support the cost of their travel and hotel accommodation. If you are an early career scientist (student or first three years of post-doc or industry) and wish to be considered for a bursary, please note this at registration.
Please note, places for this event are limited and if the meeting is oversubscribed, places will be prioritised for those who are technical practitioners in the sector. Registration deadline is 3rd July 2019 – you can register here.
For any queries please contact Marcel Kuiper, Knowledge Transfer Manager – Health.
Register today here.